Pr Philippe Moreau
- Specialty
- Hematologist, multiple myeloma expert
- Hospital
- Centre Hospitalier Universitaire de Nantes
- Latest articles
-
- Modeling Long-Term Progression-Free Survival in Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone. (Nov 9, 2026)
- Publisher Correction: Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy. (Nov 3, 2026)
- Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy. (Nov 1, 2026)
- Prognostic value of simultaneous [(18)F]FDG-PET/MRI in refractory multiple myeloma treated with anti-BCMA CAR T. (Oct 26, 2026)
- IFM 2026 Recommendations for First-line Treatment of Newly Diagnosed Multiple Myeloma. (Sep 9, 2026)